Updated gout guidelines: Don’t let kidney function dictate allopurinol dosingDecember 9, 2019Rheumatology
FDA approves infliximab-axxq for numerous indicationsDecember 6, 2019DermatologyGastroenterologyRheumatology
Study shows comparable outcomes for total hip arthroplasty vs. hemiarthroplastyDecember 4, 2019Rheumatology
Upadacitinib doubles ASAS 40 response vs. placebo in ankylosing spondylitisDecember 3, 2019Rheumatology
Certolizumab safety profile varies widely across indicationsNovember 27, 2019RheumatologyDermatologyGastroenterology
OA management guidelines forgo treatment hierarchy or order but emphasize severity, patient risk factorsNovember 24, 2019RheumatologyPain
Large population-based study underscores link between gout, CVD event riskNovember 23, 2019RheumatologyCardiology
Newer IL-17 inhibitors make their case in phase 3 nonradiographic axial spondyloarthritis trialsNovember 21, 2019Rheumatology
Fewer people are dying from systemic sclerosis at younger agesNovember 21, 2019RheumatologyRare Diseases
Rituximab tops azathioprine for relapsing ANCA-associated vasculitis remission maintenanceNovember 21, 2019Rheumatology
Apremilast for Behçet’s oral ulcers: Benefits maintained at 64 weeksNovember 19, 2019Rare DiseasesRheumatologyDermatology
FDA announces approval of fifth adalimumab biosimilar, AbriladaNovember 18, 2019GastroenterologyDermatologyRheumatologyPain
